Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a biopharmaceutical company developing and manufacturing innovative monoclonal antibodies for the treatment of cancer and serious viral infections.
Upcoming events:
Tuesday, May 1, 2012 | 1:00 PM - 5:00 PM Phosphatidylserine Asymmetry and Cell Survival: Therapeutic Applications in Cancer and Infectious DiseaseOrganizers: Ken Olive (Columbia University Medical Center), Philip Thorpe (UT Southwestern Medical Center), George Zavoico (MLV), and Jennifer Henry (The New York Academy of Sciences)
Speakers: Ari Helenius (ETH Hönggerberg), Philip Thorpe (UT Southwestern Medical Center), Chris Reutlingsperger (University of Maastricht), Alan Schroit (UT Southwestern Medical Center), and David Ucker (University of Illinois at Chicago) This symposium will highlight recent developments in the understanding of PS exposure, its biological consequences, and its exploitation to create novel agents for the detection and treatment of cancer and viral diseases.
.....................................................................................................................................................................
A new national initiative involving where volunteers can be matched to a scientific research project, or clinical trial, for which they might qualify.
Interested adult volunteers, parents or caregivers register on the ResearchMatch Web site (www.researchmatch.org) and indicate their interest in participating in research studies. Both healthy volunteers and those with specific medical conditions can sign up.
Message 26090452
CRISP has a new site for checking on grants.
projectreporter.nih.gov
Government link for definions used in trials.
prsinfo.clinicaltrials.gov
Patent office definitions:
uspto.gov |
